Revive Therapeutics (XCNQ:RVV) EPS (Basic) : C$-0.00 (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Revive Therapeutics EPS (Basic)?

Revive Therapeutics's basic earnings per share (Basic EPS) for the three months ended in Dec. 2023 was C$-0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.00.

Revive Therapeutics's EPS (Diluted) for the three months ended in Dec. 2023 was C$-0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.00.

Revive Therapeutics's EPS without NRI for the three months ended in Dec. 2023 was C$-0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was -0.00.

During the past 3 years, the average EPS without NRI Growth Rate was 28.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was -2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 10 years, Revive Therapeutics's highest 3-Year average EPS without NRI Growth Rate was 43.00% per year. The lowest was -44.20% per year. And the median was 13.30% per year.

Revive Therapeutics EPS (Basic) Historical Data

The historical data trend for Revive Therapeutics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revive Therapeutics EPS (Basic) Chart

Revive Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EPS (Basic)

Get a 7-Day Free Trial

-0.02

-0.05

-0.08

-0.06

-0.02

Revive Therapeutics Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
EPS (Basic)	Get a 7-Day Free Trial															-0.01	-0.01	-	-	-

Revive Therapeutics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Revive Therapeutics's Basic EPS for the fiscal year that ended in Jun. 2023 is calculated as

Basic EPS (A: Jun. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-6.321	-	0)	/	339.371
	=	-0.02

Revive Therapeutics's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.771	-	0)	/	357.821
	=	-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.00

Revive Therapeutics (XCNQ:RVV) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Revive Therapeutics EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Revive Therapeutics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Revive Therapeutics (XCNQ:RVV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Revive Therapeutics Ltd (XCNQ:RVV) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

RVVTF:USA 31R:Germany

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.revivethera.com

Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care.

Executives

Michael Frank

Director, Senior Officer

Revive Therapeutics (XCNQ:RVV) Headlines

No Headlines